Cargando…
Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer
Full-length (FL) docking protein-1 (DOK1) is an adapter protein which inhibits growth factor and immune response pathways in normal tissues, but is frequently lost in human cancers. Small DOK1 variants remain in cells of solid tumors and leukemias, albeit, their functions are elusive. To assess the...
Autores principales: | Friedrich, Teresa, Söhn, Michaela, Gutting, Tobias, Janssen, Klaus-Peter, Behrens, Hans-Michael, Röcken, Christoph, Ebert, Matthias P.A., Burgermeister, Elke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919572/ https://www.ncbi.nlm.nih.gov/pubmed/27428427 http://dx.doi.org/10.1016/j.ebiom.2016.05.003 |
Ejemplares similares
-
Myotubularin-related protein 7 inhibits insulin signaling in colorectal cancer
por: Weidner, Philip, et al.
Publicado: (2016) -
Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer
por: Burgermeister, Elke, et al.
Publicado: (2017) -
Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma
por: Weidner, Philip, et al.
Publicado: (2020) -
Subcellular compartmentation of glutathione in dicotyledonous plants
por: Zechmann, Bernd, et al.
Publicado: (2010) -
A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)
por: Meindl-Beinker, Nadja M., et al.
Publicado: (2019)